10-K Decoder · All companies

Corcept Therapeutics Incorporated

CORT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$761M$675M+12.8%
Operating income$44.8M$137M−67.3%
Net income$98.2M$140M−29.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026

$Q3 2026Year earlierChange
Revenue$340M$208M+64.0%
Operating income$115M$10.2M+1,025%
Net income$127M$19.7M+544%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Corcept's revenue in FY2025?
$761M in FY2025 (Fiscal year ended Dec 31, 2025), +12.8% vs $675M a year earlier, per its 10-K filed Feb 2026.
Was Corcept profitable in FY2025?
Yes: net income was $98.2M and operating income $44.8M in FY2025.
What was Corcept's revenue in Q3 2026?
$340M (+64.0% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.